<?xml version="1.0" encoding="UTF-8"?>
<ref id="B14">
 <label>14</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chen</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Ma</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Guo</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Gui</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Gai</surname>
    <given-names>Z.</given-names>
   </name>
  </person-group>
  <article-title>Farnesoid X receptor (FXR) aggravates amyloid-
   <italic>Î²</italic>-triggered apoptosis by modulating the cAMP-response element-binding protein (CREB)/brain-derived neurotrophic factor (BDNF) pathway in vitro
  </article-title>
  <source>
   <italic toggle="yes">Medical Science Monitor</italic>
  </source>
  <year>2019</year>
  <volume>25</volume>
  <fpage>9335</fpage>
  <lpage>9345</lpage>
  <pub-id pub-id-type="doi">10.12659/msm.920065</pub-id>
  <pub-id pub-id-type="pmid">31812977</pub-id>
 </element-citation>
</ref>
